Tooting, United Kingdom

Tim Bull

This inventor holds 1 USPTO granted patent. Top assignee: Temple University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tim Bull. Retrieved from https://idiyas.com/inventor/tim-bull-x034n6qh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tim Bull - Innovator in Mycobacterial Detection

Introduction

Tim Bull is a notable inventor based in Tooting, GB. He has made significant contributions to the field of medical diagnostics, particularly in the detection of mycobacterial infections. His innovative approach has the potential to enhance the accuracy and efficiency of diagnosing such infections.

Latest Patents

Tim Bull holds a patent for a "Method and system for detection of mycobacteria in human samples." This invention provides a semi-quantitative phage-based assay for mycobacterial infection. The phage assay plaque count correlates to the number of viable mycobacterial organisms in the subject sample. This method can be utilized for diagnosing, treating, or monitoring mycobacterial infections.

Career Highlights

Tim Bull is affiliated with Temple University, where he continues to advance research in his field. His work is characterized by a commitment to improving diagnostic methods and patient outcomes. With 1 patent to his name, he exemplifies the spirit of innovation in medical technology.

Collaborations

Tim has collaborated with notable colleagues, including Irene Grant and Antonio Foddai. Their combined expertise contributes to the advancement of research and development in mycobacterial detection.

Conclusion

Tim Bull's contributions to the field of medical diagnostics through his innovative patent demonstrate his dedication to improving healthcare. His work has the potential to significantly impact the diagnosis and treatment of mycobacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…